Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy.

Authors:
Pezzini A; Iacoviello L; Di Castelnuovo A; Costanzo S; Tarantino B and 31 more

Journal:
Stroke

Publication Year: 2024

DOI:
10.1161/STROKEAHA.123.044626

PMCID:
PMC10896192

PMID:
38299371

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Stroke

Abbreviation: Stroke

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Dose Response to Upper Extremity Stroke Rehabilitation Varies by Individual: Early Indicators of Tr…
Gauthier LV; Ravi R; DeLuca D and 1 more (2024) - Transparency Score: 4/6
Pericyte Microvesicles as Plasma Biomarkers Reflecting Brain Microvascular Signaling in Patients Wi…
Gaceb A; Roupé L; Enström A and 4 more (2024) - Transparency Score: 3/6
Association Between Recanalization Attempts and Functional Outcome After Thrombectomy for Large Isc…
Winkelmeier L; Faizy TD; Broocks G and 14 more (2023) - Transparency Score: 4/6
Cerebrovascular Reactivity Has Negligible Contribution to Hemodynamic Lag After Stroke: Implication…
Braban A; Leech R; Murphy K and 1 more (2023) - Transparency Score: 3/6
Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study.
Sleight E; Stringer MS; Clancy U and 23 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr Ciccone reports grants from Daiichi Sankyo, Italfarmaco, and Alexion Pharmaceuticals. Dr Paciaroni reports compensation from Sanofi-Aventis U.S. LLC, Pfizer Canada, Inc, iRhythm Technologies, Daiichi Sankyo Europe GmbH, and Bristol Myers Squibb for other services. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025